Dog Vaccine Market Scope
Vaccination plays a central role in protecting dogs from major canine infectious diseases. These include viral and bacterial diseases, which are can cause significant illness and are difficult to treat. Dogs are susceptible to a range of infectious diseases that can have a serious effect on their health and welfare. A vaccine usually contains an agent that resembles a disease-causing microorganism and killed forms of the microbe, its toxins, or its surface proteins. Vaccination plays a central role in protecting dogs from major canine infectious diseases. These include viral and bacterial diseases, which are can cause significant illness and are difficult to treat. Dogs are susceptible to a range of infectious diseases that can have a serious effect on their health and welfare.
The market study is being classified by Type (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Therapeutic Biologics and Others) and major geographies with country level break-up.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Dog Vaccine market throughout the predicted period.
Bayer AG (Germany), Sanofi (France), Elanco Animal Health (United States), Merck Sharp & Dohme Corp (United States), Virbac (France), Zoetis (United States), Phibro Animal Health Corporation (United States), Boehringer Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Vetoquinol (France) and Indian Immunologicals Ltd. (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ceva (United States), Anicon Labor (Germany), Nexvet (Australia) and Vaxxinova International B V (Netherlands).
AdvanceMarketAnalytics has segmented the market of Global Dog Vaccine market by Type, Application and Region.
On the basis of geography, the market of Dog Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Vaccine Consumption, the sub-segment i.e. Less than 6 Months will boost the Dog Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Vaccinations, the sub-segment i.e. Rabies will boost the Dog Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On April 26, 2019- Elanco Animal Health has announced that it has signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant. and On June 04, 2019- Boehringer Ingelheim has partnered with Constantia Flexibles to provide veterinarians and horse owners with Constantia Interactive, an innovative packaging solution which enhances the Nutraxin packaging with augmented reality features.
California Rabies Law- The main law can be found in the California Health and Safety Code, which is a set of state laws governing public wellbeing. The rabies law requires dog owners to obtain a new dog license at least every two years, starting once the dog is four months old. Dogs younger than four months do not have to be licensed. and Indiana Rabies Laws and Regulations- 345 IAC 1-5-2 Required rabies vaccination of dogs, cats, and ferrets (Section 2) all dogs, cats, and ferrets three (3) months of age and older must be vaccinated against rabies. The rabies vaccination of a dog, cat, and ferret shall be maintained by ongoing revaccination of the animal.
- Technological Innovations in Vaccines
- Increasing Awareness Regarding Animal Health
- Increasing Ownership of Pets
- Growing Initiatives by Government Agencies and Animal Association
- Inactivated Vaccines are Less Immunogenic
- Side Effects of Some Vaccines Such as Reactions or Allergies
- High Cost in Production of Veterinary Vaccines
Key Target AudienceManufacturers of Animal Vaccine, Suppliers of Animal Vaccine, Wholesalers, Distributors and Retailers of Animal Vaccine, Animal Welfare Associations, Veterinary Clinics and Care Centers and Governmental Bodies
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase